☰

Irina Pivneva - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Bilingualism; Executive control
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Titone D, Mercier J, Sudarshan A, Pivneva I, Gullifer J, Baum S. Spoken word processing in bilingual older adults: Assessing within- and cross-language competition using the visual world task Linguistic Approaches to Bilingualism. DOI: 10.1075/Lab.18028.Tit  0.319
2019 Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL. Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective. Leukemia & Lymphoma. 1-9. PMID 30668234 DOI: 10.1080/10428194.2018.1538510  0.354
2019 Lin F, Kwong J, Ionescu-Ittu R, Pivneva I, Wynant W, Shi S, Wu EQ, Abraham JA. Work productivity loss in patients with tenosynovial giant cell tumors in the United States. Journal of Clinical Oncology. 37: e22527-e22527. DOI: 10.1200/Jco.2019.37.15_Suppl.E22527  0.301
2018 Dana R, Bradley JL, Guerin A, Pivneva I, Evans AM, Stillman IÖ. Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study. American Journal of Ophthalmology. PMID 30312577 DOI: 10.1016/J.Ajo.2018.10.001  0.301
2018 Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ. Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. Advances in Therapy. PMID 30155792 DOI: 10.1007/S12325-018-0772-3  0.312
2018 Borghaei H, Yim YM, Guerin A, Pivneva I, Shi S, Gandhi M, Ionescu-Ittu R. Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung Cancer (Amsterdam, Netherlands). 119: 112-119. PMID 29656745 DOI: 10.1016/J.Lungcan.2018.02.011  0.346
2018 Lin F, Ionescu-Ittu R, Pivneva I, Wynant W, Shi S, Shohudi Mojdehi A, Wu E, Kwong J, Abraham JA. Disability burden in patients with tenosynovial giant cell tumors in the United States from employer perspective. Journal of Clinical Oncology. 36: 92-92. DOI: 10.1200/Jco.2018.36.30_Suppl.92  0.302
2018 Ritchie EK, Sadek I, Pivneva I, Guerin A, Latremouille-Viau D, Ndife B, Joseph GJ, Atallah EL. Symptoms following TKI therapy discontinuation after achieving an adequate response in patients with chronic myeloid leukemia in chronic phase (CML-CP). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E19024  0.319
2018 Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Joseph G, Pivneva I, Gagnon-Sanschagrin P, Tang D. Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.176  0.321
2018 Ritchie EK, Sadek I, Pivneva I, Guerin A, Latremouille-Viau D, Ndife B, Joseph GJ, Atallah EL. Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Clinical Lymphoma, Myeloma & Leukemia. 18. DOI: 10.1016/J.Clml.2018.07.091  0.309
2017 Ritchie EK, Wolff JE, Latremouille-Viau D, Guerin A, Pivneva I, Briggs O, Joseph GJ, Atallah EL. Tyrosine kinase inhibitor (TKI) therapy discontinuation in patients with CML in chronic phase: A US clinical practice perspective. Journal of Clinical Oncology. 35: 7052-7052. DOI: 10.1200/Jco.2017.35.15_Suppl.7052  0.302
2015 MERCIER J, PIVNEVA I, TITONE D. The role of prior language context on bilingual spoken word processing: Evidence from the visual world task* Bilingualism. DOI: 10.1017/S1366728914000340  0.309
2014 Pivneva I, Mercier J, Titone D. Executive control modulates cross-language lexical activation during L2 reading: evidence from eye movements. Journal of Experimental Psychology. Learning, Memory, and Cognition. 40: 787-96. PMID 24446754 DOI: 10.1037/A0035583  0.319
2014 Mercier J, Pivneva I, Titone D. Individual differences in inhibitory control relate to bilingual spoken word processing Bilingualism. 17: 89-117. DOI: 10.1017/S1366728913000084  0.31
2012 Pivneva I, Palmer C, Titone D. Inhibitory control and l2 proficiency modulate bilingual language production: evidence from spontaneous monologue and dialogue speech. Frontiers in Psychology. 3: 57. PMID 22438846 DOI: 10.3389/Fpsyg.2012.00057  0.306
2011 Pivneva I, Sudarshan A, Mercier J, Baum S, Titone D. Individual differences in executive function modulate bilingual between-language activation during reading in healthy older adults: Evidence from eye-tracking Procedia - Social and Behavioral Sciences. 23: 35-36. DOI: 10.1016/J.Sbspro.2011.09.157  0.301
Show low-probability matches.